- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Alpha Tau Medical Ltd.: Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead | 175 | GlobeNewswire (Europe) | - Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ReSTART pivotal skin cancer trial as well as trials in... ► Artikel lesen | |
| Do | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.01. | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach positiven Studiendaten | 1 | Investing.com Deutsch | ||
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.01. | Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright | 1 | Investing.com | ||
| 06.01. | Alpha Tau Medical: Aktie legt zu nach FDA-Antrag und bestätigter Kaufempfehlung | 1 | Investing.com Deutsch | ||
| 06.01. | Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating | 1 | Investing.com | ||
| 05.01. | Alpha Tau Medical Ltd.: Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) | 249 | GlobeNewswire (Europe) | - Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review... ► Artikel lesen | |
| 05.01. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 18.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14.12.25 | Alpha Tau Medical up sharply as brain cancer trial begins | 7 | Globes | ||
| 10.12.25 | H.C. Wainwright reiterates Buy rating on Alpha Tau Medical stock | 3 | Investing.com | ||
| 10.12.25 | Why Did Alpha Tau Medical (DRTS) Shares Jump Over 25% In After-Hours Trading? | 2 | Benzinga.com | ||
| 09.12.25 | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University | 189 | GlobeNewswire (Europe) | - First patient in the world treated with Alpha DaRT- in the brain - - According to the National Brain Tumor Society, glioblastoma is one of the most complex, deadly, and treatment-resistant cancers... ► Artikel lesen | |
| 09.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 02.12.25 | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer | 123 | GlobeNewswire (Europe) | JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT- , today announced that the FDA... ► Artikel lesen | |
| 02.12.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.11.25 | Alpha Tau Medical GAAP EPS of -$0.39 | 1 | Seeking Alpha | ||
| 20.11.25 | Alpha Tau Medical Ltd.: Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update | 1.403 | GlobeNewswire (Europe) | - Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study - - Newly received radioactive material license for New Hampshire facility positions the Company for continued... ► Artikel lesen | |
| 20.11.25 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.10.25 | Alpha Tau Medical stock holds Buy rating at H.C. Wainwright after license win | 1 | Investing.com |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ENVUE MEDICAL | 3,230 | 0,00 % | ENvue Medical, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 28,960 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 23,870 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,270 | 0,00 % | BrightSpring Health stock price target raised to $46 by TD Cowen | ||
| ALIGNMENT HEALTHCARE | 22,540 | 0,00 % | Alignment Healthcare (ALHC) Drops 12% on Medicare Flat Funding | ||
| SIEMENS HEALTHINEERS | 42,240 | +0,45 % | HV-Termine: Hauptversammlungen bei CGRE, Healthineers, q.beyond, Schott, Siemens, Stabilus, ThyssenKrupp, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,170 | +1,98 % | DEUTSCHE BANK RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Fresenius Medical Care (FMC) vor den anstehenden Quartalszahlen von 46 auf 44 Euro gesenkt und die Einstufung auf "Hold" belassen.... ► Artikel lesen | |
| GENEDX | 96,13 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| HEARTFLOW | 29,890 | 0,00 % | Heartflow: Wells Fargo startet Coverage mit "Overweight" und Kursziel von 38 $ | ||
| CARL ZEISS MEDITEC | 27,840 | -0,71 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Carl Zeiss Meditec von "Outperform" auf "Market-Perform" abgestuft und das Kursziel von 50,55 auf 31,00 Euro gekappt. Nach der... ► Artikel lesen | |
| FRESENIUS | 47,880 | +2,59 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
26.01.2026 /... ► Artikel lesen | |
| RXSIGHT | 8,710 | 0,00 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,220 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| BETA BIONICS | 13,820 | 0,00 % | Beta Bionics, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 24,680 | -3,74 % | Carl Zeiss Meditec, Fuchs, Gerresheimer, Hensoldt, Lanxess, Renk: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -4,28 % bei einem Aktienkurs von 6,930 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.